CoChat

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer

Open access

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

People affected by cancer want information about their prognosis but clinicians have trouble estimating and talking about it. We sought to determine the nature and accuracy of medical oncologists' estimates of life expectancy in newly referred patients with incurable cancer. With reference to each patient, medical oncologists estimated how long they thought 90, 50, and 10% of similar patients would live. These proportions were chosen to reflect worst case, predicted, and best case scenarios suitable for discussions. After a median follow-up of 35 months, 86 of the 102 patients had died with an observed median survival of 12 months. Oncologists' estimates of each patient's worst case, predicted and best case scenarios were well-calibrated: 10% of patients lived for fewer months than estimated for the worst 10% of similar patients; 50% lived for at least as long as estimated for 50% of similar patients (predicted survival), and 17% lived for more months than estimated for the best 10% of similar patients. Oncologists' estimates of each patient's predicted survival were imprecise: 29% were within 0.67-1.33 times the patient's actual survival, 35% were too optimistic (>1.33 times the actual survival), and 39% were too pessimistic (<0.67 times the actual survival). The proportions of patients with actual survival times bounded by simple multiples of their predicted survival were as follows: 61% between half to double their predicted, 6% at least three to four times their predicted, and 4% no more than 1/6 of their predicted; similar to the proportions in an exponential distribution (about 50%, 10% and 10% respectively). Ranges based on simple multiples of the predicted survival time appropriately convey prognosis and its uncertainty in newly referred people with incurable cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6602908

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Observed survival distribution (step function) and an exponential distribution based on a median survival of 12 months (smooth curve).
Figure 1 Observed survival distribution (step function) and an exponential distribution based on a median survival of 12 months (smooth curve).CC BY · PubMed Central
Figure 2 Observed versus predicted survival for each individual. Points on the 45 degree line signify people who lived exactly as long as predicted, points above the line signify people who lived longer than predicted, points below the line signify people who lived shorter than predicted. There is a strong association between predicted and observed survival (Spearman's rank correlation of 0.60, P<10−6).
Figure 2 Observed versus predicted survival for each individual. Points on the 45 degree line signify people who lived exactly as long as predicted, points above the line signify people who lived longer than predicted, points below the line signify people who lived shorter than predicted. There is a strong association between predicted and observed survival (Spearman's rank correlation of 0.60, P<10−6).CC BY · PubMed Central
Figure 3 Observed survival for subgroups with similar predicted survivals. The categories (range of included predictions, and number of patients) are: 3 months (2–4, n=10); 6 months (5–7, n=17); 9 months (8–10, n=31); 12 months (11–14, n=16); 18 months (15–20, n=10); 24 months (21–29, n=9); 36 months (>29, n=9). The boxes extend from the upper quartile (75th percentile) to the lower quartile (25th percentile) and include the middle 50% of patients. The solid circle represents the median (50th percentile). The whiskers extend to the maximum and minimum value.
Figure 3 Observed survival for subgroups with similar predicted survivals. The categories (range of included predictions, and number of patients) are: 3 months (2–4, n=10); 6 months (5–7, n=17); 9 months (8–10, n=31); 12 months (11–14, n=16); 18 months (15–20, n=10); 24 months (21–29, n=9); 36 months (>29, n=9). The boxes extend from the upper quartile (75th percentile) to the lower quartile (25th percentile) and include the middle 50% of patients. The solid circle represents the median (50th percentile). The whiskers extend to the maximum and minimum value.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 1

  1. Chye RWM, Tattersall MHN, Swanson CE (1984) An analysis of the outcome of patient referral to a medical oncology unit in a teaching hospital. Cancer Forum 8: 61–64

Cited by

See all 79

Metadata

Authors
Stockler, M. R., Tattersall, M. H. N., Boyer, M. J., Clarke, S. J., Beale, P. J., & Simes, R. J.
Affiliations
  • Royal Prince Alfred Hospital (AU)
  • The University of Sydney (AU)
Corresponding author
Stockler, M R
Venue
British Journal of Cancer
Published
2005-12-13
Volume
94
Issue
2
Pages
208-212
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2093110123
Cited by
77
References
16
Citations by year
2026: 2 · 2025: 2 · 2024: 10 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 11 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 8 · 2013: 3 · 2012: 5
FWCI
1.74
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
  • Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
Keywords
prognosis communication, life expectancy estimation, medical oncologists, incurable cancer, survival prediction, prognostic uncertainty, exponential distribution
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Female, Forecasting, Humans, Life Expectancy, Male, Medical Oncology, Middle Aged, Neoplasms, Physician-Patient Relations, Prognosis, Sensitivity and Specificity, Survival Analysis, Terminally Ill

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. https://app.cochat.ai/papers/10.1038/sj.bjc.6602908
The paper
Stockler, M. R., Tattersall, M. H. N., Boyer, M. J., Clarke, S. J., Beale, P. J., & Simes, R. J. (2006). Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6602908

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.